My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 202

    1.

    Isolation and functional characterization of recombinant GAD65 autoantibodies derived by IgG repertoire cloning from patients with type 1 diabetes.

    Jury K, Söhnlein P, Vogel M, Richter W.

    Diabetes. 2001 Sep;50(9):1976-82.PMID: 11522662 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.

    Padoa CJ, Banga JP, Madec AM, Ziegler M, Schlosser M, Ortqvist E, Kockum I, Palmer J, Rolandsson O, Binder KA, Foote J, Luo D, Hampe CS.

    Diabetes. 2003 Nov;52(11):2689-95.PMID: 14578287 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Multiplicity of the antibody response to GAD65 in Type I diabetes.

    Gilliam LK, Binder KA, Banga JP, Madec AM, Ortqvist E, Kockum I, Luo D, Hampe CS.

    Clin Exp Immunol. 2004 Nov;138(2):337-41.PMID: 15498046 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.

    Hampe CS, Nalini R, Maldonado MR, Hall TR, Garza G, Iyer D, Balasubramanyam A.

    J Clin Endocrinol Metab. 2007 Feb;92(2):462-7. Epub 2006 Nov 7.PMID: 17090641 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.

    Falorni A, Gambelunghe G, Forini F, Kassi G, Cosentino A, Candeloro P, Bolli GB, Brunetti P, Calcinaro F.

    J Clin Endocrinol Metab. 2000 Jan;85(1):309-16.PMID: 10634404 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.

    Hayakawa N, Premawardhana LD, Powell M, Masuda M, Arnold C, Sanders J, Evans M, Chen S, Jaume JC, Baekkeskov S, Smith BR, Furmaniak J.

    Autoimmunity. 2002 Aug;35(5):343-55.PMID: 12515289 [PubMed - indexed for MEDLINE]Related articles

    7.

    Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.

    Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Kockum I, Rolandsson O, Landin-Olsson M, Törn C, Persson B, Lernmark A.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4671-9.PMID: 11134126 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.

    Syren K, Lindsay L, Stoehrer B, Jury K, Lühder F, Baekkeskov S, Richter W.

    J Immunol. 1996 Dec 1;157(11):5208-14.PMID: 8943434 [PubMed - indexed for MEDLINE]Related articles

    9.

    Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.

    Walikonis JE, Lennon VA.

    Mayo Clin Proc. 1998 Dec;73(12):1161-6.PMID: 9868413 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus.

    Rickert M, Seissler J, Dangel W, Lorenz H, Richter W.

    Clin Chem. 2001 May;47(5):926-34.PMID: 11325898 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.

    Ronkainen MS, Hoppu S, Korhonen S, Simell S, Veijola R, Ilonen J, Simell O, Knip M.

    Eur J Endocrinol. 2006 Oct;155(4):633-42.PMID: 16990664 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.

    Powers AC, Bavik K, Tremble J, Daw K, Scherbaum WA, Banga JP.

    Clin Exp Immunol. 1999 Dec;118(3):349-56.PMID: 10594551 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase.

    Richter W, Shi Y, Baekkeskov S.

    Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2832-6.PMID: 7681990 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.

    Reijonen H, Daniels TL, Lernmark A, Nepom GT.

    Diabetes. 2000 Oct;49(10):1621-6.PMID: 11016444 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.

    Maioli M, Alejandro E, Tonolo G, Gilliam LK, Bekris L, Hampe CS, Obinu DA, Manconi A, Puddu L, Lynch K, Lernmark A; Study Group for the Genetics of Diabetes in Sardinia.

    J Clin Endocrinol Metab. 2004 Nov;89(11):5675-82.PMID: 15531528 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.

    Söhnlein P, Müller M, Syren K, Hartmann U, Böhm BO, Meinck HM, Knip M, Akerblom HK, Richter W.

    Diabetologia. 2000 Feb;43(2):210-7.PMID: 10753043 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.

    Schlosser M, Banga JP, Madec AM, Binder KA, Strebelow M, Rjasanowski I, Wassmuth R, Gilliam LK, Luo D, Hampe CS.

    Diabetologia. 2005 May;48(5):922-30. Epub 2005 Apr 16.PMID: 15834701 [PubMed - indexed for MEDLINE]Related articles

    18.

    Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.

    Hampe CS, Hammerle LP, Bekris L, Ortqvist E, Persson B, Lernmark A.

    J Autoimmun. 2002 Feb;18(1):49-53.PMID: 11869046 [PubMed - indexed for MEDLINE]Related articles

    19.

    Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.

    Tremble J, Morgenthaler NG, Vlug A, Powers AC, Christie MR, Scherbaum WA, Banga JP.

    J Clin Endocrinol Metab. 1997 Aug;82(8):2664-70.PMID: 9253351 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

    Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, Turck CW, Erlich H, Lennon V, Baekkeskov S.

    J Exp Med. 1994 Aug 1;180(2):595-606.PMID: 7519242 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity